Docket Nexus — Federal court records.
Company · Pharmaceuticals & Biotechnology

Amgen Inc

Federal civil lawsuits naming Amgen Inc, a Pharmaceuticals & Biotechnology company.

Ticker
Nasdaq: AMGN
Business
Biological Products, (No Diagnostic Substances)
Headquarters
Thousand Oaks, CA
Incorporated in
Delaware
SEC CIK
318154

Amgen Inc is a public company in Biological Products, (No Diagnostic Substances), based in Thousand Oaks, CA (traded on Nasdaq as AMGN, incorporated in Delaware). It appears in 229 federal civil lawsuits in this index, most often as a plaintiff (124 of 229). These cases are most often Patent and Patent - ANDA matters, filed between 1992 and 2025, most frequently in District Court, D. Delaware. The most common causes of action are Patent Infringement, Antitrust, and Personal Injury. Frequent opposing parties include Schering Corporation, Zydus Pharmaceuticals (USA), Inc, and Sandoz Inc.

229
Lawsuits
105
As Defendant
124
As Plaintiff
19
Open
210
Terminated
1992–2025
Span
13 mo
Median Duration
6.7 cases/yrPredominantly plaintiff · 54%Activity steady

Cases by State

AL — 1 casesAZ — 0 casesAR — 0 casesCA — 0 casesCO — 5 casesCT — 1 casesDE — 73 casesDC — 8 casesFL — 12 casesGA — 3 casesID — 0 casesIL — 12 casesIN — 0 casesIA — 1 casesKS — 0 casesKY — 0 casesLA — 2 casesME — 0 casesMD — 2 casesMA — 15 casesMI — 1 casesMN — 3 casesMS — 1 casesMO — 0 casesMT — 0 casesNE — 1 casesNV — 0 casesNH — 0 casesNJ — 40 casesNM — 0 casesNY — 16 casesNC — 2 casesND — 0 casesOH — 1 casesOK — 1 casesOR — 1 casesPA — 5 casesRI — 0 casesSC — 2 casesSD — 0 casesTN — 1 casesTX — 4 casesUT — 0 casesVT — 0 casesVA — 6 casesWA — 4 casesWV — 2 casesWI — 2 casesWY — 0 cases
PR · 1

Open Cases Over Time

1992peak 36 open2025

Case Types Over Time

19922025
PatentPatent - ANDAFederal Tax / Statutory ActionsContractAntitrust

Filings by Year

19922025

30 Cases — Newest First